Email this article Early administration of genetically engineered biological agents for immune-mediated inflammatory diseases: opportunities and prospects. An experts’ opinion - PDF (Russian)
Copyright (c) 2020 Abdulganieva D.I., Bakulev A.L., Belousova E.A., Veselov A.V., Korotaeva T.V., Lila A.M., Loginova E.Y., Sokolovskiy E.V., Khobeysh M.M., Shapina M.V., Shchukina O.B.
This work is licensed under a Creative Commons Attribution 4.0 International License.